Treasury Chief Rachel Reeves Plans Specific Measures on Bills in Upcoming Budget

Chancellor Reeves has revealed she is planning "focused measures to tackle cost of living challenges" in the upcoming financial statement.

During an interview with media outlets, she noted that reducing price rises is a shared task of both the administration and the central bank.

The UK's price growth is expected to be the highest among the G7 industrialized countries this year and the following year.

Potential Utility Cost Interventions

It is understood the administration could take action to bring down energy bills, for example by reducing the current 5% level of value-added tax applied on energy.

An additional possibility is to cut some of the regulatory levies currently included in household expenses.

Budgetary Limitations and Expert Predictions

The government will receive the latest draft from the official forecaster, the OBR, on the start of the week, which will reveal how much scope there is for such measures.

The expectation from most experts is that Reeves will have to announce higher taxes or budget cuts in order to meet her declared fiscal targets.

Earlier on Thursday, calculations showed there was a twenty-two billion pound shortfall for the chancellor to fill, which is at the lower end of projections.

"There's a joint responsibility between the central bank and the government to bear down further on some of the sources of inflation," the Chancellor informed the BBC in Washington, at the yearly gatherings of the IMF and global financial institution.

Tax Commitments and Global Concerns

While a great deal of the attention has been on likely tax rises, the chancellor said the latest information from the fiscal watchdog had not altered her commitment to manifesto promises not to increase rates on income tax, VAT or National Insurance.

She attributed an "uncertain world" with rising geopolitical and commercial tensions for the fiscal tax moves, likely to be directed on those "with the broadest shoulders."

International Economic Disputes

Addressing worries about the UK's trade ties with China she said: "The UK's security interests invariably come first."

Last week's announcement by China to strengthen export controls on rare earths and other materials that are essential for advanced tech manufacturing led US President the US President to suggest an additional 100% tariff on goods from the Asian country, increasing the possibility of an all-out trade war between the two largest economies.

The US Treasury Secretary described the Chinese move "commercial pressure" and "a international production control attempt."

Inquired about accepting the American proposal to join its battle with the Asian nation, Reeves said she was "extremely troubled" by Chinese actions and urged the Beijing authorities "to avoid restrictions and limit trade."

She said the move was "damaging for the international commerce and causes additional headwinds."

"I believe there are sectors where we need to address Chinese policies, but there are also valuable chances to trade with Chinese markets, including financial services and other areas of the economy. We've got to get that balance right."

The chancellor also stated she was collaborating with G7 counterparts "regarding our own critical minerals approach, so that we are more independent."

Health Service Drug Pricing and Funding

The Chancellor also admitted that the price the National Health Service pays for drugs could go up as a consequence of ongoing negotiations with the Trump administration and its pharmaceutical firms, in exchange for lower tariffs and investment.

Some of the biggest global drug companies have said recently that they are either pausing or scrapping investments in the UK, with several blaming the low prices they are getting.

Recently, the Science Minister said the price the NHS pays for drugs would have to increase to halt companies and drug research funding leaving the UK.

The Chancellor informed the BBC: "It has been observed as a result of the payment system, that clinical trials, new drugs have not been available in the UK in the extent that they are in other European countries."

"The objective is to make sure that people receiving treatment from the NHS are able to receive the best essential drugs in the globe. And so we are reviewing these issues, and... aiming to secure additional capital into the UK."